"Orlando Heart Specialists, founded by Dr. Kishore Ranadive, first opened its doors in 1997, to serve the cardiac and vascular needs of patients in the Orlando area. Over the past 20 years, Dr. Ranadive and staff has combined to offer our patients the collective experience and knowledge necessary to ensure the highest level of patient care in 2 convenient locations. At Orlando Heart Specialists we strive to go beyond the expected to deliver the most positive and caring patient encounter possible. Our Cardiologists believe communication between the doctor and the patient is essential. We are committed to caring for our community by offering full-service quality heart health care for individuals 18 and older."

During the past decade, Orlando Heart and Vascular Institute conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Orlando Heart and Vascular Institute" #1 sponsor was "Bristol-Myers Squibb" with 2 trials, followed by "CVRx, Inc." with 1 trials sponsored, "Cardio Flow, Inc." with 1 trials sponsored, "Duke University" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Orlando Heart and Vascular Institute" #1 collaborator was "Duke Clinical Research Institute" with 2 trials as a collaborator, "Pfizer" with 2 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Orlando Heart and Vascular Institute" are "Acute Coronary Syndrome" (1 trials), "Acute Coronary Syndromes" (1 trials), "Atrial Fibrillation" (1 trials), "Cardiovascular Diseases" (1 trials) and "Diabetes Mellitus, Type 2" (1 trials). Many other conditions were trialed in "Orlando Heart and Vascular Institute" in a lesser frequency.

Most popular intervention types in "Orlando Heart and Vascular Institute" are "Drug" (3 trials), "Device" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Apixaban" (3 trials), "Acetylsalicylic acid" (1 trials), "Acetylsalicylic acid placebo" (1 trials), "Barostim™ System" (1 trials) and "Intense Education Intervention" (1 trials). Other intervention names were less common.

The vast majority of trials in "Orlando Heart and Vascular Institute" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Orlando Heart and Vascular Institute". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Orlando Heart and Vascular Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Orlando Heart and Vascular Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".